Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,317.42
(
0.22%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biopearl post# 136343

Thursday, 02/02/2012 9:20:48 PM

Thursday, February 02, 2012 9:20:48 PM

Post# of 257580

Possibly but maybe not if they come equipped with an "antidote" that is relatively cheap and readily available.

None of these drugs (Pradaxa, Eliquis, Xarelto) has a known antidote.

Since basic mechanisms of action may be different also it is hard to speculate what the bleeding risk during procedures might be until we get more experience.

Eliquis and Xarelto have exactly the same MoA: inhibiting Factor Xa. Pradaxa is different: it inhibits Factor IIa (thrombin).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today